Machine Learning

At CES 2026, MeiG Smart unveiled a powerful AI module capable of running LLMs on-device, challenging industry leaders in the race to power the edge.

With a hefty war chest and a veteran leadership team, Bleichroeder Acquisition Corp. II launches its search for a high-growth tech company to take public.

The family of a motorcyclist killed by a Tesla on Autopilot files a wrongful death suit, citing a history of deceptive marketing and known system flaws.

Ascentiz unveils a groundbreaking modular exoskeleton at CES 2026, using AI and joint-specific drives to make superhuman movement an everyday reality.

At CES 2026, Chinese robotics firm RoboCT unveiled a bold strategy to turn exoskeletons from medical aids into everyday 'new organs' for all.

IDEXX prepares to release its 2025 results, with all eyes on whether its high-tech product launches can sustain momentum in a complex pet care market.

As retailers face a perfect storm of market pressures, Blue Yonder's new AI agents aim to unify planning and execution, promising greater profits and agility.

After a decade of research, a promising drug for Fragile X syndrome enters a key trial, offering hope for the first-ever targeted treatment for the disorder.

Beyond a simple time change, Fortrea's upcoming JPM presentation is a critical test for its new CEO and a key moment to define its future in the CRO market.

A novel drug that glues cancer proteins to the cellular trash system has entered human trials, offering new hope for rare diseases like Ewing sarcoma.

The Korean firm is making waves with its market-ready wearable robots and a new humanoid system courting tech giants like NVIDIA, Meta, and Amazon.

Biotech firm Bright Minds Biosciences closes a massive $175M deal, fueling its race to develop novel drugs for epilepsy and rare neurological conditions.

Promising Phase 2 data shows a new DNA immunotherapy for advanced melanoma, delivered via a needle-free jet injector, significantly improves patient outcomes.

A new alliance aims to advance KFRX06, a unique Parkinson's therapy that goes beyond a single target to potentially offer a more comprehensive treatment.

A new $50M venture fund from Penn, BioNTech, and OUP aims to turn the university's breakthrough research into life-saving therapies faster than ever.

Maria Montenegro, an AI and M&A expert, takes the helm of the CP & ESG unit, signaling a major push into tech-driven corporate compliance and performance.

With a new board appointment and $19M in funding, Enhanced Genomics is leveraging its 3D genomics platform to build its own pipeline of precision therapies.

With a new Deputy CEO and CFO, newcleo accelerates its mission to power the world with recycled nuclear waste, reshaping the global energy landscape.

Automated Industrial Robotics Inc. acquires Ireland's KAON Automation, a strategic move to dominate the high-stakes medical and life sciences market.

With a major Series B led by IDG Capital, PhotonPay is accelerating its mission to re-architect global payments with a stablecoin-native infrastructure.